Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:05 PM
Ignite Modification Date:
2025-12-24 @ 5:05 PM
NCT ID:
NCT02884050
Eligibility Criteria:
Inclusion Criteria:
* Men or women (post menopausal or using approved birth control methods
Exclusion Criteria:
* Presence of clinically significant cardiovascular, endocrine, hematopoietic, hepatic, neurologic, psychiatric, or renal disease
* Presence or history of drug or alcohol abuse
* The use of concomitant medications which are known to affect topiramate or the use of any concomitant medications that may alter cognitive function, including antidepressants, anxiolytics, psychostimulants such Ritalin, prescribed analgesics, and antipsychotics.
* Prior adverse reaction to or prior hypersensitivity to topiramate or to related compounds
* Subjects who have received any investigational drug within the previous thirty days
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT02884050
Study Brief:
Protocol Section:
NCT02884050